C
DexCom, Inc.
DXCM
$77.84
-$1.67-2.10%
C
Hold
1/21/2025Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 1/21/2025 due to an increase in the volatility index, total return index and efficiency index.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 1/21/2025 due to an increase in the volatility index, total return index and efficiency index.
D
Sell
10/2/2024Downgrade
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 10/2/2024 due to a decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 10/2/2024 due to a decline in the total return index and volatility index.
C
Hold
9/18/2024Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 9/18/2024 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $0.3583 to $0.3512.
DexCom, Inc. (DXCM) was downgraded to C- from C on 9/18/2024 due to a decline in the volatility index, growth index and total return index. Earnings per share declined from $0.3583 to $0.3512.
C
Hold
1/8/2024Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 1/8/2024 due to an increase in the total return index and volatility index.
DexCom, Inc. (DXCM) was upgraded to C from C- on 1/8/2024 due to an increase in the total return index and volatility index.
C
Hold
11/20/2023Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 11/20/2023 due to a decline in the growth index, valuation index and total return index.
DexCom, Inc. (DXCM) was downgraded to C- from C on 11/20/2023 due to a decline in the growth index, valuation index and total return index.
C
Hold
10/27/2023Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 10/27/2023 due to an increase in the solvency index, volatility index and efficiency index. Debt to equity declined from 1.54 to 1.14, the quick ratio increased from 2.12 to 2.4, and net income increased 4.14% from $115.9M to $120.7M.
DexCom, Inc. (DXCM) was upgraded to C from C- on 10/27/2023 due to an increase in the solvency index, volatility index and efficiency index. Debt to equity declined from 1.54 to 1.14, the quick ratio increased from 2.12 to 2.4, and net income increased 4.14% from $115.9M to $120.7M.
C
Hold
10/26/2023Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 10/26/2023 due to a noticeable decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to C- from C on 10/26/2023 due to a noticeable decline in the total return index and volatility index.
C
Hold
8/14/2023Downgrade
DexCom, Inc. (DXCM) was downgraded to C from C+ on 8/14/2023 due to a decline in the total return index, efficiency index and volatility index.
DexCom, Inc. (DXCM) was downgraded to C from C+ on 8/14/2023 due to a decline in the total return index, efficiency index and volatility index.
C
Hold
7/28/2023Upgraded
DexCom, Inc. (DXCM) was upgraded to C+ from C on 7/28/2023 due to a significant increase in the growth index, total return index and valuation index. EBIT increased 171.4% from $47.2M to $128.1M, earnings per share increased from $0.12 to $0.2774, and operating cash flow increased 22.46% from $155.4M to $190.3M.
DexCom, Inc. (DXCM) was upgraded to C+ from C on 7/28/2023 due to a significant increase in the growth index, total return index and valuation index. EBIT increased 171.4% from $47.2M to $128.1M, earnings per share increased from $0.12 to $0.2774, and operating cash flow increased 22.46% from $155.4M to $190.3M.
C
Hold
10/18/2022Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 10/18/2022 due to an increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to C from C- on 10/18/2022 due to an increase in the total return index.
C
Hold
7/29/2022Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 7/29/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from $0.2334 to $0.1246.
DexCom, Inc. (DXCM) was downgraded to C- from C on 7/29/2022 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from $0.2334 to $0.1246.
C
Hold
4/29/2022Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 4/29/2022 due to a significant increase in the growth index, efficiency index and total return index. EBIT increased 6,783.33% from $600 to $41.3M, net income increased 601.55% from -$19.4M to $97.3M, and earnings per share increased from -$0.2 to $0.9338.
DexCom, Inc. (DXCM) was upgraded to C from C- on 4/29/2022 due to a significant increase in the growth index, efficiency index and total return index. EBIT increased 6,783.33% from $600 to $41.3M, net income increased 601.55% from -$19.4M to $97.3M, and earnings per share increased from -$0.2 to $0.9338.
C
Hold
2/16/2022Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C+ on 2/16/2022 due to a significant decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.71 to -$0.2, EBIT declined 99.49% from $118.3M to $600, and operating cash flow declined 57.22% from $247.3M to $105.8M.
DexCom, Inc. (DXCM) was downgraded to C- from C+ on 2/16/2022 due to a significant decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.71 to -$0.2, EBIT declined 99.49% from $118.3M to $600, and operating cash flow declined 57.22% from $247.3M to $105.8M.
C
Hold
1/26/2022Downgrade
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 1/26/2022 due to a major decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 1/26/2022 due to a major decline in the total return index and volatility index.
B
Buy
1/11/2022Upgraded
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 1/11/2022 due to a noticeable increase in the total return index and valuation index.
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 1/11/2022 due to a noticeable increase in the total return index and valuation index.
C
Hold
12/20/2021Downgrade
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 12/20/2021 due to a substantial decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 12/20/2021 due to a substantial decline in the total return index and volatility index.
B
Buy
12/8/2021Downgrade
DexCom, Inc. (DXCM) was downgraded to B- from B on 12/8/2021 due to a decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to B- from B on 12/8/2021 due to a decline in the total return index.
B
Buy
11/16/2021Upgraded
DexCom, Inc. (DXCM) was upgraded to B from B- on 11/16/2021 due to a substantial increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.87 to 0.81.
DexCom, Inc. (DXCM) was upgraded to B from B- on 11/16/2021 due to a substantial increase in the total return index, volatility index and solvency index. Debt to equity declined from 0.87 to 0.81.
B
Buy
7/30/2021Upgraded
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 7/30/2021 due to a substantial increase in the growth index and total return index. Operating cash flow increased 121.58% from $27.8M to $61.6M, EBIT increased 120.04% from $45.9M to $101M, and earnings per share increased from $0.41 to $0.63.
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 7/30/2021 due to a substantial increase in the growth index and total return index. Operating cash flow increased 121.58% from $27.8M to $61.6M, EBIT increased 120.04% from $45.9M to $101M, and earnings per share increased from $0.41 to $0.63.
C
Hold
6/10/2021Upgraded
DexCom, Inc. (DXCM) was upgraded to C+ from C on 6/10/2021 due to an increase in the total return index and volatility index.
DexCom, Inc. (DXCM) was upgraded to C+ from C on 6/10/2021 due to an increase in the total return index and volatility index.
C
Hold
5/12/2021Downgrade
DexCom, Inc. (DXCM) was downgraded to C from C+ on 5/12/2021 due to a large decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to C from C+ on 5/12/2021 due to a large decline in the total return index.
C
Hold
5/3/2021Downgrade
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 5/3/2021 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $3.4016 to $0.41, operating cash flow declined 83.84% from $172M to $27.8M, and EBIT declined 55.87% from $104M to $45.9M.
DexCom, Inc. (DXCM) was downgraded to C+ from B- on 5/3/2021 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $3.4016 to $0.41, operating cash flow declined 83.84% from $172M to $27.8M, and EBIT declined 55.87% from $104M to $45.9M.
B
Buy
4/28/2021Upgraded
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 4/28/2021 due to a major increase in the total return index and volatility index.
DexCom, Inc. (DXCM) was upgraded to B- from C+ on 4/28/2021 due to a major increase in the total return index and volatility index.
C
Hold
2/12/2021Upgraded
DexCom, Inc. (DXCM) was upgraded to C+ from C on 2/12/2021 due to a major increase in the efficiency index, valuation index and growth index. Net income increased 391.97% from $72.2M to $355.2M, earnings per share increased from $0.73 to $3.4016, and operating cash flow increased 16.53% from $147.6M to $172M.
DexCom, Inc. (DXCM) was upgraded to C+ from C on 2/12/2021 due to a major increase in the efficiency index, valuation index and growth index. Net income increased 391.97% from $72.2M to $355.2M, earnings per share increased from $0.73 to $3.4016, and operating cash flow increased 16.53% from $147.6M to $172M.
C
Hold
10/20/2020Downgrade
DexCom, Inc. (DXCM) was downgraded to C from C+ on 10/20/2020 due to a large decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to C from C+ on 10/20/2020 due to a large decline in the total return index.
C
Hold
10/2/2020Upgraded
DexCom, Inc. (DXCM) was upgraded to C+ from C on 10/2/2020 due to an increase in the total return index, volatility index and valuation index.
DexCom, Inc. (DXCM) was upgraded to C+ from C on 10/2/2020 due to an increase in the total return index, volatility index and valuation index.
C
Hold
9/15/2020Downgrade
DexCom, Inc. (DXCM) was downgraded to C from C+ on 9/15/2020 due to a significant decline in the total return index and efficiency index.
DexCom, Inc. (DXCM) was downgraded to C from C+ on 9/15/2020 due to a significant decline in the total return index and efficiency index.
C
Hold
7/29/2020Upgraded
DexCom, Inc. (DXCM) was upgraded to C+ from C on 7/29/2020 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 8,010.53% from $1.9M to $154.1M, earnings per share increased from $0.21 to $0.48, and EBIT increased 65.77% from $40.9M to $67.8M.
DexCom, Inc. (DXCM) was upgraded to C+ from C on 7/29/2020 due to a significant increase in the growth index, total return index and volatility index. Operating cash flow increased 8,010.53% from $1.9M to $154.1M, earnings per share increased from $0.21 to $0.48, and EBIT increased 65.77% from $40.9M to $67.8M.
C
Hold
5/18/2020Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 5/18/2020 due to an increase in the volatility index, total return index and efficiency index.
DexCom, Inc. (DXCM) was upgraded to C from C- on 5/18/2020 due to an increase in the volatility index, total return index and efficiency index.
C
Hold
4/30/2020Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 4/30/2020 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 98.68% from $143.7M to $1.9M, earnings per share declined from $1.0047 to $0.21, and EBIT declined 60.41% from $103.3M to $40.9M.
DexCom, Inc. (DXCM) was downgraded to C- from C on 4/30/2020 due to a substantial decline in the growth index and valuation index. Operating cash flow declined 98.68% from $143.7M to $1.9M, earnings per share declined from $1.0047 to $0.21, and EBIT declined 60.41% from $103.3M to $40.9M.
C
Hold
4/7/2020Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 4/7/2020 due to a large increase in the total return index and volatility index.
DexCom, Inc. (DXCM) was upgraded to C from C- on 4/7/2020 due to a large increase in the total return index and volatility index.
C
Hold
3/23/2020Downgrade
DexCom, Inc. (DXCM) was downgraded to C- from C on 3/23/2020 due to a large decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to C- from C on 3/23/2020 due to a large decline in the total return index and volatility index.
C
Hold
2/18/2020Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 2/18/2020 due to a substantial increase in the growth index, efficiency index and total return index. Net income increased 102.4% from $45.8M to $92.7M, earnings per share increased from $0.5 to $1.0047, and EBIT increased 75.68% from $58.8M to $103.3M.
DexCom, Inc. (DXCM) was upgraded to C from C- on 2/18/2020 due to a substantial increase in the growth index, efficiency index and total return index. Net income increased 102.4% from $45.8M to $92.7M, earnings per share increased from $0.5 to $1.0047, and EBIT increased 75.68% from $58.8M to $103.3M.
C
Hold
11/7/2019Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 11/7/2019 due to an increase in the total return index, efficiency index and solvency index. Net income increased 536.19% from -$10.5M to $45.8M, debt to equity declined from 1.52 to 1.39, and total capital increased 4% from $1.79B to $1.86B.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 11/7/2019 due to an increase in the total return index, efficiency index and solvency index. Net income increased 536.19% from -$10.5M to $45.8M, debt to equity declined from 1.52 to 1.39, and total capital increased 4% from $1.79B to $1.86B.
D
Sell
10/23/2019Downgrade
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 10/23/2019 due to a decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 10/23/2019 due to a decline in the total return index.
C
Hold
8/19/2019Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/19/2019 due to a major increase in the total return index and efficiency index. Net income increased 60.97% from -$26.9M to -$10.5M, and total capital increased 2.35% from $1.75B to $1.79B.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/19/2019 due to a major increase in the total return index and efficiency index. Net income increased 60.97% from -$26.9M to -$10.5M, and total capital increased 2.35% from $1.75B to $1.79B.
D
Sell
7/29/2019Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 7/29/2019 due to an increase in the growth index, solvency index and volatility index. EBIT increased 93.2% from -$164.6M to -$11.2M, and earnings per share increased from -$2.0269 to -$0.2979.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 7/29/2019 due to an increase in the growth index, solvency index and volatility index. EBIT increased 93.2% from -$164.6M to -$11.2M, and earnings per share increased from -$2.0269 to -$0.2979.
D
Sell
4/18/2019Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 4/18/2019 due to a large decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 4/18/2019 due to a large decline in the total return index.
D
Sell
3/12/2019Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 3/12/2019 due to a large increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 3/12/2019 due to a large increase in the total return index.
D
Sell
2/25/2019Downgrade
DexCom, Inc. (DXCM) was downgraded to D from C on 2/25/2019 due to a significant decline in the growth index, efficiency index and total return index. EBIT declined 1,284.17% from $13.9M to -$164.6M, earnings per share declined from $0.52 to -$2.0269, and net income declined 485.62% from $46.6M to -$179.7M.
DexCom, Inc. (DXCM) was downgraded to D from C on 2/25/2019 due to a significant decline in the growth index, efficiency index and total return index. EBIT declined 1,284.17% from $13.9M to -$164.6M, earnings per share declined from $0.52 to -$2.0269, and net income declined 485.62% from $46.6M to -$179.7M.
C
Hold
11/7/2018Upgraded
DexCom, Inc. (DXCM) was upgraded to C from C- on 11/7/2018 due to a major increase in the growth index, total return index and efficiency index. EBIT increased 383.67% from -$4.9M to $13.9M, net income increased 54.3% from $30.2M to $46.6M, and earnings per share increased from $0.34 to $0.52.
DexCom, Inc. (DXCM) was upgraded to C from C- on 11/7/2018 due to a major increase in the growth index, total return index and efficiency index. EBIT increased 383.67% from -$4.9M to $13.9M, net income increased 54.3% from $30.2M to $46.6M, and earnings per share increased from $0.34 to $0.52.
C
Hold
8/7/2018Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/7/2018 due to an increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/7/2018 due to an increase in the total return index.
D
Sell
8/2/2018Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 8/2/2018 due to a major increase in the growth index, total return index and efficiency index. Operating cash flow increased 575.86% from -$8.7M to $41.4M, net income increased 224.79% from -$24.2M to $30.2M, and earnings per share increased from -$0.2772 to $0.34.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 8/2/2018 due to a major increase in the growth index, total return index and efficiency index. Operating cash flow increased 575.86% from -$8.7M to $41.4M, net income increased 224.79% from -$24.2M to $30.2M, and earnings per share increased from -$0.2772 to $0.34.
D
Sell
11/3/2017Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 11/3/2017 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from $0.03 to -$0.0231.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 11/3/2017 due to a substantial decline in the growth index, total return index and volatility index. Earnings per share declined from $0.03 to -$0.0231.
D
Sell
8/3/2017Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 8/3/2017 due to a substantial increase in the growth index, efficiency index and volatility index. Operating cash flow increased 4,666.67% from $300 to $14.3M, net income increased 106.95% from -$41.7M to $2.9M, and earnings per share increased from -$0.4894 to $0.03.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 8/3/2017 due to a substantial increase in the growth index, efficiency index and volatility index. Operating cash flow increased 4,666.67% from $300 to $14.3M, net income increased 106.95% from -$41.7M to $2.9M, and earnings per share increased from -$0.4894 to $0.03.
D
Sell
5/22/2017Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 5/22/2017 due to a noticeable decline in the total return index, growth index and solvency index. EBIT declined 562.3% from -$6.1M to -$40.4M, earnings per share declined from -$0.0875 to -$0.4894, and operating cash flow declined 97.74% from $13.3M to $300.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 5/22/2017 due to a noticeable decline in the total return index, growth index and solvency index. EBIT declined 562.3% from -$6.1M to -$40.4M, earnings per share declined from -$0.0875 to -$0.4894, and operating cash flow declined 97.74% from $13.3M to $300.
D
Sell
5/1/2017Downgrade
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 5/1/2017 due to a decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 5/1/2017 due to a decline in the total return index and volatility index.
C
Hold
4/5/2017Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 4/5/2017 due to a major increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 4/5/2017 due to a major increase in the total return index.
D
Sell
3/21/2017Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 3/21/2017 due to an increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 3/21/2017 due to an increase in the total return index.
D
Sell
3/3/2017Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 3/3/2017 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 42.17% from $23M to $13.3M, and the quick ratio declined from 2.37 to 2.2.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 3/3/2017 due to a noticeable decline in the growth index, total return index and solvency index. Operating cash flow declined 42.17% from $23M to $13.3M, and the quick ratio declined from 2.37 to 2.2.
D
Sell
11/2/2016Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 11/2/2016 due to a major increase in the growth index, efficiency index and valuation index. Operating cash flow increased 14.43% from $20.1M to $23M, total revenue increased 8.23% from $137.3M to $148.6M, and EBIT increased 7.96% from -$20.1M to -$18.5M.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 11/2/2016 due to a major increase in the growth index, efficiency index and valuation index. Operating cash flow increased 14.43% from $20.1M to $23M, total revenue increased 8.23% from $137.3M to $148.6M, and EBIT increased 7.96% from -$20.1M to -$18.5M.
D
Sell
10/25/2016Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 10/25/2016 due to a large decline in the total return index and volatility index.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 10/25/2016 due to a large decline in the total return index and volatility index.
D
Sell
10/10/2016Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 10/10/2016 due to an increase in the total return index and valuation index.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 10/10/2016 due to an increase in the total return index and valuation index.
D
Sell
9/23/2016Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 9/23/2016 due to a decline in the total return index.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 9/23/2016 due to a decline in the total return index.
D
Sell
9/8/2016Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 9/8/2016 due to a noticeable increase in the total return index.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 9/8/2016 due to a noticeable increase in the total return index.
D
Sell
3/11/2016Downgrade
DexCom, Inc. (DXCM) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
DexCom, Inc. (DXCM) was downgraded to D from D+ on 3/11/2016 due to a significant decline in the volatility index and total return index.
D
Sell
11/6/2015Downgrade
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 11/6/2015 due to a significant decline in the growth index, total return index and efficiency index.
DexCom, Inc. (DXCM) was downgraded to D+ from C- on 11/6/2015 due to a significant decline in the growth index, total return index and efficiency index.
C
Hold
8/6/2015Upgraded
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/6/2015 due to a noticeable increase in the volatility index, growth index and efficiency index. Operating cash flow increased 382.35% from $3.4M to $16.4M, total revenue increased 28.02% from $72.8M to $93.2M, and total capital increased 14.08% from $152.7M to $174.2M.
DexCom, Inc. (DXCM) was upgraded to C- from D+ on 8/6/2015 due to a noticeable increase in the volatility index, growth index and efficiency index. Operating cash flow increased 382.35% from $3.4M to $16.4M, total revenue increased 28.02% from $72.8M to $93.2M, and total capital increased 14.08% from $152.7M to $174.2M.
D
Sell
2/27/2015Upgraded
DexCom, Inc. (DXCM) was upgraded to D+ from D on 2/27/2015 due to a significant increase in the total return index, volatility index and growth index. Total revenue increased 22.17% from $69M to $84.3M.
DexCom, Inc. (DXCM) was upgraded to D+ from D on 2/27/2015 due to a significant increase in the total return index, volatility index and growth index. Total revenue increased 22.17% from $69M to $84.3M.
NASDAQ
03/07/2025 3:00PM Eastern
Quotes delayed
